KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CELU
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Celularity Inc. stock price on Friday which ended trading at $3.02
(Updated on Apr 26, 2024)

Sell candidate since Apr 12, 2024 Loss -26.52% PDF

The Celularity Inc. stock price fell by -1.63% on the last day (Friday, 26th Apr 2024) from $3.07 to $3.02. During the last trading day the stock fluctuated 16.07% from a day low at $2.89 to a day high of $3.36. The price has fallen in 6 of the last 10 days and is down by -26.52% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -190 thousand shares and in total, 49 thousand shares were bought and sold for approximately $147.89 thousand.

Given the current short-term trend, the stock is expected to rise 105.71% during the next 3 months and, with a 90% probability hold a price between $6.21 and $19.71 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CELU Signals & Forecast

There are few to no technical positive signals at the moment. The Celularity Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.14 and $4.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -56.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Celularity Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.465 between high and low, or 16.07%. For the last week the stock has had daily average volatility of 13.35%.

Celularity Inc. is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CELU) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Celularity Inc. to open at $3.09, and during the day (based on 14 day Average True Range), to move between $2.57 and $3.47, which gives a possible trading interval of +/-$0.449 (+/-14.88%) up or down from last closing price. If Celularity Inc. takes out the full calculated possible swing range there will be an estimated 29.76% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.07, some $0.0500 (1.66%) from the current price of $3.02, our system finds the risk reward not very attractive.

Is Celularity Inc. stock A Buy?

The Celularity Inc. stock holds several negative signals and despite the positive trend, we believe Celularity Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.602 Sell Candidate Unchanged

Predicted Opening Price for Celularity Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$3.09 ( 2.37%) $3.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CELU

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.56 17.77 %
R2 3.38 11.89 %
R1 3.27 8.26 %
Current price: 3.02
Support S1 2.91 -3.51 %
S2 2.80 -7.15 %
S3 2.63 -13.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.58 18.54 %
R2 3.50 15.89 %
R1 3.07 1.66 %
Current price 3.02
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Celularity Inc. Stock and on which exchange is it traded?
The symbol for Celularity Inc. is CELU and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celularity Inc. Stock?
The Celularity Inc. stock holds several negative signals and despite the positive trend, we believe Celularity Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Celularity Inc. Stock?
Celularity Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celularity Inc. Stock.

What's the current price of Celularity Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Celularity Inc. (CELU) share was $3.02.

What is the 52-week high and low for Celularity Inc. Stock?
The 52-week high for Celularity Inc. Stock is $7.97 and the 52-week low is $0.159.

What is the market capitalization of Celularity Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Celularity Inc. is 65.784M.

When is the next earnings date for Celularity Inc.?
The upcoming earnings date for Celularity Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Celularity Inc.

Celularity. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-... CELU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT